# A Study of BLYG8824A in Participants With Locally Advanced or Metastatic Colorectal Cancer

> **NCT04468607** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 46 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** BLYG8824A

## Key facts

- **NCT ID:** NCT04468607
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-31
- **Primary completion:** 2024-10-16
- **Final completion:** 2024-10-16
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04468607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04468607, "A Study of BLYG8824A in Participants With Locally Advanced or Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04468607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*